This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pneumococcal Infections or HIV Infections
and you are
between 13 and 39
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

HIV-infected people and pregnant women are at risk of developing severe pneumococcal disease. The purpose of this study is to compare the safety and immune response to two pneumococcal vaccines in HIV-infected pregnant women.

Provided treatments

  • Biological: PPV-23 Vaccine
  • Biological: PCV-13 Vaccine
  • Biological: Placebo Vaccine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01443117. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 0 volunteers for the current phase.
Official trial title:
Administration of Polysaccharide or Conjugated Pneumococcal Vaccines to HIV-Infected Pregnant Women: Safety and Magnitude, Persistence, and Transplacental Transfer of Vaccine-Serotype Pneumococcal Anti-Capsular Antibodies